Toru Kuratani
Overview
Explore the profile of Toru Kuratani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
194
Citations
1596
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kudo T, Kuratani T, Sawa Y, Miyagawa S
Circ J
. 2024 Oct;
PMID: 39443099
Background: This study analyzed the risk factors for type 1a endoleak after hybrid thoracic endovascular repair (TEVAR) for aortic arch diseases based on preoperative patient characteristics and multidetector computed tomography...
2.
Tominaga T, Ichibori Y, Nakawatase S, Mori N, Sakamoto T, Kuratani T, et al.
Cardiovasc Interv Ther
. 2024 Mar;
39(3):329-330.
PMID: 38491328
No abstract available.
3.
Handa K, Ohata T, Sekiya N, Nakamura T, Kuratani T, Masai T
Indian J Thorac Cardiovasc Surg
. 2024 Feb;
40(2):159-170.
PMID: 38389777
Introduction: In the context of double-valve surgery for elderly high-risk patients involving both the aortic and mitral valves, a clinically significant problem has been that no clear criteria or surgical...
4.
Yamana F, Kuratani T, Domae K, Sakamoto T, Hata M, Shirakawa Y, et al.
J Endovasc Ther
. 2023 Dec;
:15266028231214206.
PMID: 38050851
Purpose: To evaluate the usefulness of a hybrid treatment strategy for acute type A aortic dissection (AAAD). Methods: We retrospectively evaluated the outcomes of 39 partial arch replacements (PAR; 26...
5.
Shijo T, Shimamura K, Maeda K, Yamashita K, Ide T, Yamana F, et al.
J Endovasc Ther
. 2023 Oct;
:15266028231206993.
PMID: 37882164
Purpose: The effectiveness of thoracic endovascular aortic repair (TEVAR) for chronic aortic dissection (AD) with aneurysmal degeneration remains controversial. We retrospectively investigated clinical outcomes and assessed predictors of aortic shrinkage...
6.
Nakae M, Kainuma S, Toda K, Yoshikawa Y, Hata H, Yoshioka D, et al.
JTCVS Open
. 2023 Oct;
15:211-219.
PMID: 37808015
Objective: In patients with ischemic cardiomyopathy, coronary artery bypass grafting ensures better survival than medical therapy. However, the long-term clinical impact of complete revascularization remains unclear. This observational study aimed...
7.
Kudo T, Kuratani T, Sawa Y, Miyagawa S
J Clin Med
. 2023 Aug;
12(16).
PMID: 37629368
Hybrid thoracic endovascular aortic repair (TEVAR) without median sternotomy is increasingly being performed in high-risk patients with aortic arch disease. The outcomes of hybrid TEVAR were reported to be worse...
8.
Ide T, Shimamura K, Shijo T, Kuratani T, Sakaniwa R, Miyagawa S
Eur J Vasc Endovasc Surg
. 2023 Jun;
66(4):513-520.
PMID: 37330200
Objective: This study aimed to investigate the impact of the number of patent lumbar arteries (LAs) on sac enlargement after endovascular aneurysm repair (EVAR). Methods: This was a retrospective cohort...
9.
Kudo T, Kuratani T, Sawa Y, Miyagawa S
J Endovasc Ther
. 2023 May;
32(1):170-184.
PMID: 37222467
Purpose: Hybrid thoracic endovascular aortic repair (TEVAR) for aortic arch aneurysms is a minimally invasive procedure with improved results. This study aimed to clarify the effectiveness and expand the possibilities...
10.
Mori D, Miyagawa S, Kawamura T, Yoshioka D, Hata H, Ueno T, et al.
Cell Transplant
. 2023 Jan;
32:9636897221148457.
PMID: 36624995
Although mesenchymal stem cell transplantation has been successful in the treatment of ischemic cardiomyopathy, the underlying mechanisms remain unclear. Herein, we investigated whether mitochondrial transfer could explain the success of...